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Medical and Financial Risks Associated with Surgery in the Elderly Obese
Abstract
OBJECTIVE: To study the medical and financial outcomes associated with surgery in elderly obese
patients and to ask if obesity itself influences outcomes above and beyond the effects from comorbidities
that are known to be associated with obesity.
BACKGROUND: Obesity is a surgical risk factor not present in Medicare's risk adjustment or payment
algorithms, as BMI is not collected in administrative claims.
METHODS: A total of 2045 severely or morbidly obese patients (BMI ≥ 35 kg/m, aged between 65 and 80
years) selected from 15,914 elderly patients in 47 hospitals undergoing hip and knee surgery, colectomy,
and thoracotomy were matched to 2 sets of 2045 nonobese patients (BMI = 20-30 kg/m). A "limited
match" controlled for age, sex, race, procedure, and hospital. A "complete match" also controlled for 30
additional factors such as diabetes and admission clinical data from chart abstraction.
RESULTS: Mean BMI in the obese patients was 40 kg/m compared with 26 kg/m in the nonobese. In the
complete match, obese patients displayed increased odds of wound infection: OR (odds ratio) = 1.64
(95% CI: 1.21, 2.21); renal dysfunction: OR = 2.05 (1.39, 3.05); urinary tract infection: OR = 1.55 (1.24,
1.94); hypotension: OR = 1.38 (1.07, 1.80); respiratory events: OR = 1.44 (1.19, 1.75); 30-day readmission:
OR = 1.38 (1.08, 1.77); and a 12% longer length of stay (8%, 17%). Provider costs were 10% (7%, 12%)
greater in obese than in nonobese patients, whereas Medicare payments increased only 3% (2%, 5%).
Findings were similar in the limited match.
CONCLUSIONS: Obesity increases the risks and costs of surgery. Better approaches are needed to reduce
these risks. Furthermore, to avoid incentives to underserve this population, Medicare should consider
incorporating incremental costs of caring for obese patients into payment policy and include obesity in
severity adjustment models.
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OBJECTIVE—To study the medical and financial outcomes associated with surgery in the
elderly obese patient and ask if obesity itself influences outcomes above and beyond effects from
comorbidities known to be associated with obesity.
BACKGROUND—Obesity is a surgical risk factor not present in Medicare’s risk adjustment or
payment algorithms, as BMI is not collected in administrative claims.
METHODS—2045 severely or morbidly obese patients (BMI ≥ 35 kg/m2, age between 65 and
80) selected from 15,914 elderly patients in 47 hospitals undergoing hip and knee surgery,
colectomy, and thoracotomy were matched to two sets of 2045 non-obese patients (BMI = 20 – 30
kg/m2). A “limited match” controlled for age, sex, race, procedure and hospital. A “complete
match” also controlled for 30 additional factors such as diabetes and admission clinical data from
chart abstraction.

ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Dr. Jeffrey H. Silber, Center for Outcomes Research, The
Children’s Hospital of Philadelphia, 3535 Market Street, Suite 1029, Philadelphia, PA 19104. (T) 215-590-5635; (F) 215-590-2378;
silberj@wharton.upenn.edu.
CONFLICTS OF INTEREST: None
DISCLOSURE OF FUNDING: National Institutes of Health (NIH)

Silber et al.

Page 2

NIH-PA Author Manuscript

RESULTS—Mean BMI in the obese was 40kg/m2 versus 26kg/m2 in the non-obese. In the
complete match, obese patients displayed increased odds of wound infection: OR = 1.64 (95% CI
1.21, 2.21); renal dysfunction: OR = 2.05(1.39, 3.05); urinary tract infection: OR = 1.55 (1.24,
1.94); hypotension: OR = 1.38 (1.07, 1.80); respiratory events: OR = 1.44 (1.19, 1.75); 30-day
readmission: OR = 1.38 (1.08, 1.77); and a 12% longer length of stay (8%, 17%); Provider costs
were 10% (7%, 12%) greater in the obese than non-obese, while Medicare payments increased
only 3% (2%, 5%). Findings were similar in the limited match.
CONCLUSIONS—Obesity increases the risks and costs of surgery. Better approaches are needed
to reduce these risks. Furthermore, to avoid incentives to under-serve this population, Medicare
should consider incorporating incremental costs of caring for obese patients into payment policy
and include obesity in severity adjustment models.

INTRODUCTION

NIH-PA Author Manuscript

The epidemic of obesity in American now extends to the elderly population, where over 38
percent of 65 to 80 year olds have a Body Mass Index (BMI) that exceeds 30 kg/m2, and 15
percent exceed 35 kg/m2.1 Though obesity may increase the need for surgery, the decision to
perform general and orthopedic surgery on the obese elderly patient is a difficult one,
requiring caregivers to calculate potential risks and benefits with a paucity of
information.2–21 Given the scope of the problem, there have been relatively few large
studies concerning the surgical risks associated with obesity in the elderly,2, 3, 16–19, 21 in
part because administrative claims do not collect BMI22. Furthermore, as BMI is not
collected, it cannot be used for severity adjustment in Medicare’s payment algorithms.
Hence, obesity in the elderly represents a challenge that is important, complex and at the
same time understudied in the Medicare population.

NIH-PA Author Manuscript

In a 47 hospital study of Medicare patients in three states,23 we use claims analysis and chart
review with multivariate matching24–28 to study differences in medical and financial
outcomes between obese and non-obese elderly patients 65 to 80 years of age. The obese are
compared to two matched comparison groups, a “limited match” that controls for age, sex,
race, procedure and hospital, and a “complete match” that also controls for comorbid
conditions commonly associated with obesity. The complete match asks a hypothetical
question: How would the outcomes and costs of an obese and a non-obese patient compare if
both patients had comorbities, such as hypertension and diabetes, often found among the
obese? Outcomes examined in this study will be that of mortality, complications,
readmissions, length of stay, and financial costs and payments. We find important “specific”
effects from obesity, above and beyond those problems attributed to its associated
comorbidities, suggesting a need for new approaches to care for, and pay for, the elderly
obese surgical patient.

METHODS
Study Overview
The Obesity and Surgical Outcomes Study (OBSOS)23 is a study of surgery at 47 hospitals
located throughout Illinois, New York and Texas. Using Medicare claims, elderly patients
between the ages of 65 and 80 were identified undergoing one of five types of surgery
between 2002 and 2006: (1) hip replacement or revision excluding fracture (ICD9CM
Principal Procedure codes 81.51-81.53); (2) knee replacement or revision (ICD9CM
Principal Procedure 81.54, 81.55); (3) colectomy for cancer (ICD9CM Principal Procedure
codes 45.7-45.79, 45.8) (ICD9CM Principal Diagnosis codes 153-153.9, 154-154.8,
230.3-6); (4) colectomy not for cancer (ICD9CM Principle Procedure 45.7-45.79, 45.8) and
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(ICD9CM Principal Diagnosis codes 562.1-562.13); and (5) thoracotomy (ICD9CM
Principal Procedure codes 32-32.9).

NIH-PA Author Manuscript

Hospitals were contacted by the Oklahoma Foundation for Medical Quality (OFMQ), and
requested to abstract between 300 and 400 pre-specified charts in order to collect baseline
information including body mass index (BMI), admission vital signs and laboratory tests,
and information on the surgical procedure. All data collected was de-identified and merged
with encrypted Medicare claims files and sent to the study investigators for analysis.
Approval was obtained from The Children’s Hospital of Philadelphia IRB (the IRB
associated with the PI of the study), as well as hospital specific IRBs when requested.
Statistical Methods
Overview—We define obesity as a BMI > 30.29 Furthermore, for descriptive ease, we
define a BMI ≥ 35 but less than 40 as “severely” obese and a BMI ≥ 40 as “morbidly”
obese. Building upon our earlier Surgical Outcomes Study,24, 27, 30 the present OBSOS
study was designed to compare cases of patients who were severely and morbidly obese
(BMI ≥ 35 kg/m2) to non-obese (20 ≤ BMI < 30) elderly surgical controls in Medicare with
respect to outcomes, such as survival and complications, length of stay and readmission
rates, and Medicare payments and resource utilization costs. The study design called for
matching with different subsets of prognostic factors.

NIH-PA Author Manuscript

The Matching Algorithm—As described above, a “limited” match and a “complete”
match were constructed using the same matching methods but different matching variables.
The limited match controlled for procedure, age, sex, race, and hospital, while the complete
match also controlled for 30 conditions associated with obesity, other clinical data from
chart abstraction such as an approximate APACHE score 27, 30, 31, transfer status, and
admission from the emergency department. Diabetes was defined using both information
abstracted from the chart and information obtained from claims. Using the variables
appropriate for that match, the match was implemented using fine balance,25, 32 a propensity
score25, 33 for being obese, as well as a risk of mortality or prognostic score34 based on
claims data whose parameters were independently estimated from all hospitals in Illinois,
New York and Texas not included in this study. Fine balance ensured that a hospital that
provided, say, 100 obese knee surgery patients for the match also provided 100 non-obese
knee surgery patients for the match, so that the distribution of knee surgery patients over
hospitals is identical in the obese and non-obese groups.

NIH-PA Author Manuscript

Specific effects of obesity on outcomes would be suggested if both ‘limited” and “complete”
match results displayed similar differences between the obese and the non-obese. If the
“limited” match detected differences between the obese and the non-obese patients but these
differences disappeared in the “complete” match, this would suggest that the differences in
outcomes observed between groups could be explained in terms of comorbidities associated
with obesity and not by obesity itself.
In order to ensure good matching quality, we sought a minimum pool of 2.5 controls (nonobese elderly patients with BMI’s ≥ 20 kg/m2 and < 30 kg/m2) to each obese elderly case
(where cases needed to be severely or morbidly obese with BMI’s at least 35 kg/m2). For all
procedures, except knees, the matching ratio was greater than 2.5. For knee procedures, the
proportion of obese patients was higher, so that the matching ratio was less than 2.5. To
ensure a matching ratio greater than 2.5, we randomly sampled a subset of patients from the
knee group that were severely or morbidly obese, to ensure the minimum ratio. Of 1,425
severely or morbidly obese knee patients, we randomly sampled 1028 to achieve a matching
ratio of 2.6. For all other procedures, we utilized all available obese patients (with BMIs ≥
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35 kg/m2). The overall matching ratio in the study was 4.5 controls per case (2045 cases and
9177 potential controls).
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Defining Payments and Costs—Total payments and costs reflect expenses incurred
during the patient’s index admission, as well as during any subsequent encounters beginning
after discharge but within 30 days of admission, regardless of length, excluding non-acute
care and rehabilitation costs (Diagnosis Related Groups [DRG] 462). All results are
expressed in 2008 dollars. Payments were defined by applying the standardized Payment
Calculation Worksheets, available from ResDAC,35 to the Medicare Inpatient, Hospital
Outpatient and Carrier files. Total payments equal the sum of payments from Medicare
(both DRG-based and per diem amounts), beneficiary coinsurance and deductibles, and
payments from other primary payers.

NIH-PA Author Manuscript

Hospital costs were calculated using two methods. Method 1 was based on resource
utilization.36, 37 Each patient’s stay was categorized into critical care days or non-critical
care days based on revenue center in the inpatient file, and assigned national daily average
prices for each category.38 For the patient’s index admission, the cost of the operating room
time was added by multiplying the anesthesia time obtained from the Physician Part B/
Carrier file by an average per-minute operating room cost.39 If anesthesia time was not
available, the patient was assigned the median anesthesia time for their procedure category.
Physician services were priced by assigning each service recorded in the Carrier file its 2008
Relative Value Units, which were then converted to dollar amounts. Finally, to capture the
additional cost of visits to an emergency department following discharge (as opposed to
follow-up care in a physician’s office), patients were assigned an additional cost for each
unique emergency department visit, reflecting the facility component of the cost.40 Method
2 was based on total hospital charges drawn from the Medicare Inpatient and Outpatient
files multiplied by annual, hospital-specific cost-to-charge ratios obtained from CMS Cost
Reports, and also included resource use estimates for office encounters. Method 1 will yield
more conservative estimates of cost because it is difficult to account for all dimensions of
resources and overheads, but viewing both methods can be thought of as lower and upper
estimates, as one builds cost from the ground up while the other does the reverse. See
technical appendix for details.
Statistical Tests

NIH-PA Author Manuscript

Balance on observed variables after matching was appraised using standard two-sample tests
that contrast achieved balance with the magnitude of covariate balance anticipated from
completely random assignment.33 When testing the hypothesis of no difference in outcomes
between the matched obese and non-obese patients, the Wilcoxon sign-rank statistic41 for
paired data and its associated confidence interval and Hodges-Lehmann point estimate were
used for continuous variables, and the McNemar statistic42 for paired data was used for
categorical variables. When comparing survival-type distributions between the matched
groups, the paired Prentice-Wilcoxon test43 for censored data was used.

RESULTS
Study Hospital Characteristics
Table 1 describes the 47 hospitals. Names of the hospitals are in the electronic appendix.
Approximately 47% of hospitals were non-teaching, and 6% were “very major” teaching
hospitals (having a resident-to-bed ratio greater than 0.60).44–46 Hospital size varied
considerably, with the inter-quartile range being between 256 and 539 beds.
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Match Quality: Did Each Match Achieve Balance in the Variables Matched On?
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The quality of the limited and complete matches is presented in Table 2, which describes the
obese, the non-obese matched for many variables by the “complete” algorithm, and the nonobese matched for a few variables by the “limited” algorithm. A complete list of matching
variables is in the electronic appendix. Each match successfully balanced those specific
variables it was supposed to balance. In the limited match that meant no significant
difference in age, sex, race and procedure (and the risk and propensity scores based on these
variables). In the complete match that meant no difference in age, sex, race, procedure as
well as all additional variables in the complete match such as diabetes and history variables
as well as a more complex propensity score and risk score now comprised of far more
variables than in the limited match. In both matches, all hospital attributes are perfectly
balanced.

NIH-PA Author Manuscript

Table 2 is organized so that the description of the non-obese patients of the complete match
is to the immediate right of the obese patients, and farther to the right are the non-obese
patients in the limited match. At the top of Table 2 are the unmatched variables that define
obesity (BMI, height and weight), followed by variables controlled for in both matches,
followed by variables controlled in the complete match but not the limited match. If a
variable, such as diabetes, was controlled for in the complete but not the limited match, then
we expect to see a rate of diabetes in the limited match controls that is typical of leaner
patients and a rate of diabetes in the complete match controls that is typical of severely
obese patients, though both matched controls are not obese. In obese patients, the rate of
diabetes was 39%. The non-obese in the complete match had a diabetes rate of 39% (no
different than the obese), whereas in the limited match, which did not match on diabetes, the
rate of diabetes in the non-obese was only 19%, which was different beyond the P < 0.0001
level. In other words, as expected, non-obese patients undergoing the same surgical
procedures as the obese had a much lower rate of diabetes, but after matching for diabetes,
along with many other comorbidities, there was no difference in the rate of diabetes between
groups. This same result applies to each characteristic that was matched in the complete
match, and not in the limited match. For all variables that were matched on, there was no
difference between the obese and the non-obese.
Medical Outcomes

NIH-PA Author Manuscript

Table 3 describes the 30- and 180-day mortality, in-hospital or 30-day complications, length
of stay, readmission rates, costs and payments. There were no significant differences in
mortality between the obese and non-obese patients. Figure 1 displays the overlapping
Kaplan-Meier survival curves for the obese, and the matched pairs using the limited and
complete matching algorithms.
Complications were more common in the obese patients when compared to both the limited
and complete matched non-obese patients. In the limited match, the odds of a wound
infection were increased almost two-fold in the obese patients, and after complete
adjustment, the two-fold increase was maintained (P < 0.0009). The odds of developing
sepsis was significantly increased by 90% in the limited match (P < 0.0042) and stayed
elevated at 81% increase (P < 0.0097) after adding the complete matching variables. The
odds of respiratory system complications were increased by 44% in the obese, (P < 0.00012)
and this increased risk remained similar in the complete match. The odds of developing a
venous thromboembolism (VTE) were 47% higher (P < 0.01) in the obese in the complete
match, but were not significantly elevated in the limited match. The odds of developing a
urinary tract infection (UTI) were 85% higher (P < 0.00001) in the obese using the limited
match and declined to 55% higher (P < 0.0001) using the complete match. Pyelonephritis
was rare, but more common in the obese when using the limited match (P < 0.039), but
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failed to reach significance in the complete match. Renal complications were increased
almost three-fold in the obese using the limited match (P<0.00001), and two-fold in the
complete match (P < 0.00015). Similarly, the odds of hypotension were increased 27% in
the obese using the limited match (P < 0.059), and a 38% elevation was observed in the
complete matched analysis (P < 0.013). The odds of a cardiac event were twice as high in
the obese than in the non-obese using the limited match (P < 0.00001). However, the odds
were less elevated after using the complete matching variables, suggesting less of a specific
effect from obesity because non-obese patients with similar comorbidities also developed
similar rates of cardiac complications. The odds of central nervous system complications,
internal organ damage, post-operative bleeding, decubitus ulcers, and orthopedic
complications were not significantly different between obese and non-obese patients.
The obese also displayed a 12% longer length of stay than their non-obese counterparts in
the complete match (P < 0.00001), and 15% longer in the limited match (P < 0.00001). Of
note, the upper 90th percentiles were 10 days in the obese and 9 and 8 days in the complete
and limited matches respectively.

NIH-PA Author Manuscript

The odds of being readmitted were between 40% to 60% higher in the obese than in the nonobese. Figure 2 displays a Kaplan-Meier plot of alive without readmission over the first 30
days from discharge. These increased readmission rates were apparent using both the limited
and complete matches.
Financial Outcomes, Financial Risks
For the complete match, Medicare payments were 3% greater for the obese than the nonobese, P < 0.00001. However, using cost to charge ratios, costs were 10% greater for the
obese than the non-obese (P < 0.00001), and 10% greater using resource derived costs (P <
0.00001). As shown in Table 3, formally testing the difference between these cost and
payment ratios displayed large and highly significant results, suggesting that the increased
costs associated with the obese were not accompanied by similar increases in payments. We
found similar differences in the limited match.

NIH-PA Author Manuscript

To better understand the financial risks associated with performing surgery on the obese as
compared to the non-obese, we calculated the difference in “contribution margin” or profit
(payment – cost) between the obese and the non-obese, and studied how obesity was
associated with profitability (profit in the obese - profit in the non-obese). In one sense,
studying the profit from a single surgical procedure is difficult, because there are many
costs, such as the costs associated with preventing hospital acquired infections or having
spare capacity in the ICU, that cannot be assigned to individual patients, yet presumably are
not reasonably assigned equally to procedures that differ greatly in their length and
complexity. In another sense, with our matched pairs, studying the difference in profit,
obese-versus-nonobese, is less difficult because every hospital contributes the same number
of patients to the obese and nonobese groups from every surgical category. If a hospital’s
overhead cost for colectomy with cancer differs from overhead cost for knee surgery, this
fixed difference will cancel in our matched comparison of obese and nonobese. Using the
complete match, and costs based on resource consumption, we grouped each of the study
matched pairs (obese to non-obese) into categories of profitability by displaying the absolute
value of the difference in profit between the obese and non-obese. Table 4 breaks the 2,009
matched pairs (36 of the 2,045 pairs were not analyzed due to missing resource data) into
three groups: the pairs with less than a $1,000 difference in profitability; pairs having
between a $1,001 and $10,000 difference, and pairs with more than a $10,000 difference in
profit between the obese and non-obese matched pair. We then ask which member of the
pair was more profitable. There were 322 matched pairs where the difference in profitability
was small, (less than $1,000). Among these, the obese patient was less profitable than the
Ann Surg. Author manuscript; available in PMC 2013 April 11.
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non-obese matched control in 171/322 of these pairs and in 151/322 pairs the obese patient
was more profitable than the non-obese matched control, yielding an odds of 1.13 (95% CI .
90, 1.42), P = 0.290, suggesting no significant association between obesity and profit status
among the matched pairs when there was only a small difference in profitability. However,
as the size of the difference in profitability increased, the odds that the less profitable patient
in the matched pair was obese became larger and statistically significant. In 539 pairs where
the difference in profitability was more than $10,000, the obese patient was less profitable
than the non-obese matched control in 313/539 of these pairs and in 226/539 pairs the obese
patient was more profitable than the non-obese matched control, yielding an odds of 1.38
(95% CI 1.16, 1.65), P < 0.00021, suggesting a strong association between obesity and less
profitable status when large differences in profitability were observed.

DISCUSSION
Our study found large and significant elevations in the risks of readmission in the elderly
obese and greater risks of many complications, without a significant increase in mortality.
Furthermore, consistent with these elevated risks, we found substantial differences in costs
between the obese and non-obese, yet much smaller differences in payments.

NIH-PA Author Manuscript

Using limited and complete matches, we distinguished specific risks of obesity from risks
caused by diseases associated with obesity. We found that the risks of complications and
readmission due to obesity were often evident even after matching on comorbidities
associated with obesity. This suggests that obesity’s specific adverse effects are, in part,
separate from comorbidities associated with obesity. This important information should aid
surgeons to more accurately risk-stratify patients during preoperative evaluation,
appropriately educate patients about postoperative expectations, and provide information
about areas of postoperative management that may be targets for quality improvement. For
example, we observed an over 40% increase in readmission rates in the obese versus the
non-obese, whether we matched using the limited or complete match. Given much higher
rates of readmission, and the importance of readmissions to patient care and resource
consumption,47 our study suggests a need to re-evaluate current discharge criteria for obese
patients and a need to re-design how we manage obese elderly patients after discharge.48–50
Additionally, in an era of public reporting of surgical outcomes and pay for performance,
measurement of and adjustment for patient BMI may be critical for accurate risk adjustment.
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The matched design of this study also allowed us to better examine the extent that obesity
influences Medicare payments and provider costs. Establishing that the specific effects of
obesity are associated with excess medical risks and financial costs, beyond those costs from
comorbidities associated with obesity (like diabetes and heart disease), would suggest that
patient BMI should be included in administrative data. Under Medicare’s current
reimbursement system, the obese are typically less profitable than similar non-obese
patients, but separately and in addition, the obese also present a much greater risk of being
substantially unprofitable patients. When an obese and non-obese pair of patients
undergoing the same procedure differed substantially in profitability, by more than $10,000,
the odds were 4-to-3 that the obese patient was the substantially less profitable patient.
Medicare could compensate providers for the typically greater cost and greater risk in cost
for the obese patient by incorporating BMI in its payment formula. In fact, current proposals
head in the opposite direction. If Medicare reduces payments for readmissions when the
obese are more likely to be readmitted, the difference in profitability will likely grow larger,
not smaller.
The literature has often displayed conflicting results concerning the effect of obesity on
outcomes, and none have utilized matching to formally analyze profitability differences
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between obese and non-obese patients. Dindo et al.,2 as well as others,11, 20 have suggested
that obesity is not, with only some isolated exceptions, associated with increased
complications. In contrast, there are studies reporting increased complications in the
obese.3–5, 7, 9, 10, 12–14, 16–18, 21 Most studies have not demonstrated increased near-term
mortality associated with obesity,2, 6, 7, 9, 10, 13 though some have reported an increased risk
of mortality in the morbidly obese,21 or super obese17 (BMI’s greater than 50 kg/m2). With
respect to our finding concerning renal complications, again, there have been disparate
results. Suleiman et al.20 in a study of total knee and hip arthroplasty, did not observe an
increase in renal complications, or any other complications. However, their population, with
a mean age of 65 years, was younger than our study population and the sample included less
than 500 severely or morbidly obese patients. Others have found increased renal
complications.16,19 Our results of an elevated risk of renal abnormalities were consistent
with a report by Merkow et al. in colon cancer surgery19. The Merkow study involved a
comparison of obese and non-obese colectomy for cancer cases in which 12.4 percent had
BMI’s above 35 kg/m2 (396 patients) and of those patients, roughly half were older than 65
years. They found approximately an odds ratio of 1.71 for developing renal failure when
comparing their group having BMI greater than 35 kg/m2 to that having BMI between 25
and 29 kg/m2, whereas our study reports an odds ratio of 2.05 for a category having BMI 35
kg/m2 or greater compared to that having BMI between 20 and 30 kg/m2 in the complete
match and 2.67 in the limited match. Of interest, we found that the odds of hypotension were
also elevated for the obese in both the limited and complete matches. Exploring practice
styles for fluid resuscitation, drug dosing and anesthetic techniques may help us understand
the elevated rates observed in the obese for both of these complications.
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Our study has limitations. The obese patients we examined all underwent surgery after
having satisfied the preoperative risk stratification used by their surgeons, and therefore
these patients may have had less risk than the typical obese patient desiring, but possibly not
receiving, surgery. This would lead to underestimating differences in outcomes between the
obese and non-obese that would have occurred without such selection. While selection bias
is a possibility, it would have to have been produced by variables other than those controlled
for in the complete match in Table 2. Furthermore, we did not study resources associated
with non-acute care or rehabilitation, which may have been greater in the obese. Also, our
economic analysis was dependent on Medicare claims, not specific hospital accounting
systems. While we can precisely measure what Medicare paid to their providers, we cannot
determine exact costs, which may vary by hospital. However, we did present two different
methods for estimating these costs that yielded very similar differences in cost between
obese and non-obese patients. Additionally, for each procedure group, say knee surgery,
each of the 47 hospitals contributed exactly the same number of obese and non-obese
patients to our study. As a consequence, an unmeasured fixed cost that affects in the same
way all knee surgeries in one hospital will be equally represented in our obese and nonobese groups and will not bias our comparison.
In conclusion, surgery on the obese elderly patient is associated with significantly increased
medical risks and financial costs. To reduce these risks, it will be important to understand
and remedy specific problems associated with obesity itself, both in the hospital and after
discharge. Furthermore, Medicare should include obesity status in risk adjustment models
and consider incorporating the incremental costs of caring for the obese elderly patient into
payment policy. Not doing so may create incentives to under-serve this population,
especially since providers appear to be taking on far more financial risk when operating on
obese patients than their non-obese counterparts.
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Figure 1. Kaplan Meier plot of percent alive by days from admission

The obese group is depicted by a solid red line, the non-obese limited match is depicted by
the gray short-dashed line, and the non-obese complete match is the blue long-dashed line.
As can be seen, there is no difference in survival between the obese and either the complete
or limited match.
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Figure 2. Kaplan Meier plot of percent alive without readmission by days from discharge

The obese group is depicted by a solid red line, the non-obese limited match is depicted by
the gray short-dashed line, and the non-obese complete match is the blue long-dashed line.
There is a considerable difference in the readmission rates between the obese and both nonobese groups.
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Table 1

Study Hospital Characteristics

NIH-PA Author Manuscript

Number of Hospitals

47

Size (Beds) mean (std)

423 (285)

Size Distribution, %
0–200

15

201–400

40

401–600

28

601–800

11

800

6

Nurse to bed ratio,* mean (SD)

1.64 (0.44)

Nurse Mix,† mean (SD)

0.91 (0.08)

Technology index,‡ %

77

NIH-PA Author Manuscript

Teaching intensity based on resident to bed ratio, %
Nonteaching (RB ratio = 0)

47

Very minor (0 < RB ≤ 0.05)

15

Minor (0.05 < RB ≤ 0.25)

19

Major (0.25 <RB ≤ 0.6)

13

Very major (0.6 < RB ≤ 1.1)

6

Location, (%)
Illinois

38

New York

17

Texas

45

*

Full time equivalent registered nurses/number of beds.

†

Registered nurses/(registered nurses + licensed practical nurses)

‡

Technology index = 1 if hospital performs open-heart surgery, organ transplantation, or has a burn unit; otherwise index = 0.
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Table 2

Matching Results

NIH-PA Author Manuscript

Complete Match (Nonobese) N =
2045

Limited Match (Nonobese) N =
2045

39.74

26.30f

26.14f

Weight, mean, kg

108.20

74.43f

73.78f

Height, mean, cm

164.85

167.91f

167.68f

Variables

Obese N = 2045

BMI, mean

Limited matching variables (controlled in both matches)
Age, yrs

71.54

71.53

71.43

Sex, male, %

33.40

34.87

33.55

White, %

90.66

91.83

91.30

Black, %

6.85

5.62

6.50

Other, %

2.49

2.54

2.20

Hip, %

25.33

25.33

25.33

Knee, %

50.27

50.27

50.27

Colectomy for cancer, %

10.42

10.42

10.42

Colectomy not for cancer, %

4.84

4.84

4.84

Thoracotomy, %

9.14

9.14

9.14

30-day mortality (predicted probability)

0.01

0.01

0.01

Propensity to be obese (probability)

0.25

0.24

0.21

Race:

Procedure:

NIH-PA Author Manuscript

Additional variables for complete match (controlled in the complete but not the limited match)
Diabetes:

NIH-PA Author Manuscript

No Diabetes, %

61.22

60.73

81.32f

Diabetes w/o meds, %

12.03

12.13

7.97f

Diabetes with meds, %

26.75

27.14

10.71f

Transfer-in, %

0.44

0.24

0.24

Admission from emergency department, %

4.50

3.96

4.50

APACHE score (mean)

23.88

23.81

22.95f

Hx asthma, %

11.39

9.88

6.85f

Hx chronic lung disease, %

19.66

18.88

18.88

Hx collagen vascular disease, %

4.79

3.81

6.70a

Hx dementia, %

1.86

1.17

3.23b

20.59

18.44

17.36b

Hx hepatic abnormalities, %

3.47

3.13

4.79a

Hx renal dysfunction, %

4.65

4.55

2.25f

Hx renal failure, %

3.77

3.47

1.86e

Hx hypothyroidism, %
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Variables

Obese N = 2045

Complete Match (Nonobese) N =
2045

Limited Match (Nonobese) N =
2045

NIH-PA Author Manuscript

Hx smoking, %

7.87

7.19

9.54

Hx weight loss, %

1.47

1.27

2.89c

Hx stroke, %

3.91

3.37

4.11

Hx paraplegia, %

0.49

0.39

0.49

Hx hypertension, %

85.57

85.87

71.44f

Hx congestive heart failure, %

15.40

14.77

8.26f

5.43

5.48

4.60

20.73

21.52

17.80a

3.18

2.74

3.67

11.54

11.25

10.46

Hx myocardial infarction, %
Hx arrhythmia, %
Hx angina, %
Hx valvular heart disease, %

P values compare nonobese to obese
a

< 0.05;

b

< 0.01;

NIH-PA Author Manuscript

c

< 0.005;

d

< 0.001;

e

< 0.0005;

f

<0.0001. The limited match includes Age, Sex, Procedure, and Race, as well as a limited risk and propensity score using these 4 variables. The
complete match adds a total of 36 patient variables including those listed previously. Look, for instance, at diabetes. For full list, see Electronic
Appendix. Displayed earlier included, but not limited to, all variables where there were any significant differences between obese and nonobese.
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2.75

1.18
2.85

Death 30 days

Death 180 days

6.33
3.09
19.53
5.74
4.91
11.04
8.24
10.99
0.39
4.50
9.03
26.40
1.37
4.17

Wound infection

Sepsis

Respiratory

Venous thromboembolism

Central neurological events

Cardiac events

Hypotension/shock

Urinary T=tract infection

Pyelonephritis

Renal dysfunction

Internal organ damage

Bleeding (surgical or GI)

Decubitis ulcer

Orthopedic complications

Complications 30 days
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4.46

1.13

28.20

7.65

2.40

0.20

7.41

6.23

9.12

4.66

3.92

15.65

1.91

3.97

0.83

Obese %

Outcome Measures

Nonobese Complete
Match %

NIH-PA Author Manuscript

Surgical Outcome Results

4.22

0.88

26.90

8.10

1.81

0.05

6.33

6.63

6.87

5.55

4.76

15.46

1.72

4.17

2.99

1.03

Nonobese Limited
Match %

0.92

1.23

0.91

1.25

2.05

2.00

1.55

1.38

1.32

1.06

1.47

1.44

1.81

1.64

1.04

1.50

OR†

(0.66, 1.29)

(0.67, 2.26)

(0.79, 1.05)

(0.95, 1.64)

0.99

1.59

0.97

1.16

2.67

(1.39, 3.05)e

1.85

(1.24, 1.94)e

8.00

1.27

(1.07, 1.80)a

(0.54, 9.07)

1.69

1.23

(1.09, 2.00)a

(1.04, 1.67)a

1.44

(1.19, 1.75)e

0.87

1.9

(1.14, 2.90)b

(0.78, 1.44)

1.59

0.95

1.16

OR†

(0.70, 1.39)

(0.83, 3.10)

(0.84, 1.13)

(0.90, 1.49)

(1.77, 4.11)f

(1.07, 355)a

(1.46, 2.35)f

(0.99, 1.63)

(1.35, 2.14)f

(0.65, 1.16)

(0.92, 1.64)

(1.19, 1.75)e

(1.21, 3.04)c

(1.18, 2.16)c

(0.64, 1.40)

(0.60, 2.26)

95% CI

Nonobese Limited Match

(1.21, 2.21)d

(0.69, 1.58)

(0.73, 3.19)

95% CI

Nonobese Complete Match
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10.0 (9, 10)

90th percentile (95% CI)
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11,655 (11,469 11,938)
33,164 (30,329, 35,757)

15,736 (15,541, 15,952)
29,872 (28,746, 31,052)

Median (95% CI)

90thpercentile (95% CI)

Median (95% CI)

90thpercentile
(95% CI)

31,798 (30,069, 33,562)

90thpercentile (95% CI)

< 0.0005;

e

< 0.001;

d

< 0.005;

c

< 0.01;

< 0.05;

b

a

P values compare obese to nonobese:

Medicare
Payments
(Payment) †
($)

Costs ($)
(Estimated
Using
Resources)

16,779 (16,443, 16,994)

Obese

Costs and Payments, In-hospital or
Within 30 Days

Median (95% CI)

9.24

30 days

Costs ($)
(Estimated
Using Costto-Charge
Ratios)

3.90

7 days

Readmission or death

4.0 (4.0, 4.0)

Median (95% CI)

Length of stay, days

Obese %

NIH-PA Author Manuscript

Outcome Measures

NIH-PA Author Manuscript
28,768 (27,504, 29,880)

15,622 (15,422, 15,835)

29,388 (27,370, 32,164)

11,251 (11,003, 11,443)

27,822 (26,614, 29,647)

15,970 (15,698, 16,213)

Nonobese Complete

6.92

2.44

9.0 (8, 9)

4.0 (4.0, 4.0)

28,160 (27,155 29,448)

15,542 (15,344 15,748)

28,716 (25,981, 30,644)

11,211 (10,997, 11,433)

27,534 (26,331, 29,339)

15,993 (15,661, 16,260)

Nonobese Limited

6.25

2.50

8.0 (8, 9)

4.0 (4.0, 4.0)

Nonobese Limited
Match %

1.03f (1.02, 1.05)

-------

0.08f (0.05, 0.10)

0.06f (0.04, 0.08)

1.10f (1.07, 1.12)

1.10f (1.08, 1.13)

Cost Ratio
Minus PMT
Ratio Complete

Ratio* (Obese
to Nonobese)
Complete

1.03f (1.02, 1.05)

1.11f (1.09, 1.14)

1.10f (1.08, 1.13)

Ratio* (Obese
to Nonobese)
Limited

1.53

(1.08, 1.77)b

1.38

1.15f

Ratio* (Obese
to Nonobese)

OR†

1.67

95% CI (1.08,
1.17)

95% CI

-------

0.08f (0.06, 0.10)

0.06f (0.04, 0.08)

Cost Ratio
Minus PMT
Ratio Limited

(1.20, 1.96)d

(1.13, 2.50)a

95% CI (1.11,
1.21)

95% CI

Nonobese Limited Match

(1.08, 2.27)a

1.56

1.12f

Ratio* (Obese
to Nonobese)

OR†

Nonobese Complete Match

NIH-PA Author Manuscript

Nonobese Complete
Match %
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OR: Odds ratio comparing obese with nonobese.

†

H-L: Hodges-Lehmann Estimator.

*

<0.0001.
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600
313

>10,000

226

1.38:1

1.09:1

1.13:1

Odds of Obese Being Less Profitable
Than the Nonobese

1.16–1.65

0.98–1.23

0.90–1.42

95% CI

0.00021

0.12498

0.28966

P

Profitability is the difference in profit between the nonobese and the obese. Profit is payment minus cost, computed within each matched pair, using the complete match and resource-based costs. We
analyzed 2009 of the 2045 pairs; 36 were deleted because of incomplete resource information. For profit differences greater than $10,000, obese patients were far more likely to be less profitable than their
matched nonobese controls.

*

151

171

0–1000

1001–10,000

548

Pairs Where Nonobese Patient
Was Less Profitable

Pairs Where Obese Patient Was
Less Profitable

Absolute Difference in Profit Between Obese
and Nonobese Matched Control, $

NIH-PA Author Manuscript

Profitability* in Obese and Nonobese Matched Pairs
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